Maca Sleep Randomized Trial: What the Evidence Says

Quick Answer

Maca Sleep Randomized Trial has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are mixed biomedical and public-health sources, so conclusions should be framed as evidence-aware guidance rather than medical advice.

Key Takeaways

• This page is generated only from sources stored in the Migaku evidence knowledge base.
• Current evidence mix: 2 preclinical study.
• Claims should be interpreted with the source type, study design, population, and publication date in mind.
• This article is educational and does not replace care from a qualified clinician.

Evidence Map

What The Sources Report

• It is associated with increased risk of stroke, heart failure, hospitalization, and mortality, placing a substantial clinical and economic burden on healthcare systems. [Sokolova Emma (2026); evidence level 4]
• For example, studies suggest that up to 30-40% of patients with AF report cognitive complaints or sleep disturbances, both of which are associated with reduced quality of life and increased healthcare utilization. [Sokolova Emma (2026); evidence level 4]
• By synthesizing molecular evidence from the BDNF/TrkB/CREB signaling axis and the Nrf2/NF-κB homeostatic switch, we demonstrate that this multi-target strategy offers a more robust path to neuronal resilience than traditional single-target approaches. [Cipriano GL (2026); evidence level 4]
• This narrative review proposes the 'Brain Health Triad' as a novel integrative framework for neurorehabilitation and cognitive enhancement, built upon three interdependent biological pillars: neurostimulation, neurotrophy, and neuroprotection. [Cipriano GL (2026); evidence level 4]

How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

Practical Interpretation

For maca sleep randomized trial, the current source set is useful for orientation, but it is not yet broad enough for strong claims. Use cautious language and keep conclusions close to the cited sources.

Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

References

• Sokolova Emma (2026). Integrating Patient-Reported Outcomes into Clinical Pathways in Atrial Fibrillation: A Framework Aligned with the AF-CARE Model. DOI: 10.3390/diagnostics16091398. PMCID: PMC13163613. PMID: 42122101. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13163613/
• Cipriano GL (2026). Phytochemical and Fungal Bioactive Compounds in the "Brain Health Triad": A Narrative Review on Neurostimulating, Neurotrophic, and Neuroprotective Synergy.. DOI: 10.3390/ijms27083607. PMCID: PMC13116414. PMID: 42074246. https://pmc.ncbi.nlm.nih.gov/articles/PMC13116414/

Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.